Clinical Trials Browser

Phase EARLY_PHASE1 × Recurrence × 30 days × Clear all

NCT03445858 2026-02-18

Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults

Phase EARLY_PHASE1 Completed

Lymphoma, Neoplasms, Recurrence